Focused on regenerative medicine technologies, the company develops systems designed to isolate and process stem cells derived from adipose (fat) tissue for therapeutic use. Its platform, including the Icellator device, aims to enable same‑day cell therapies used in clinical and research settings. I...
No congressional trades have been disclosed for Tissue Genesis Holdings Inc (TSGH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.